D. Geoffrey Shulman
David Geoffrey Shulman | |
|---|---|
| Born | July 8, 1954 Toronto, Ontario, Canada |
| Died | July 2, 2012 (aged 57) Toronto, Ontario, Canada |
Resting place | Pardes Shalom Cemetery |
| Other name | Geoffrey Shulman |
| Occupations | Dermatologist and pharmaceutical executive |
| Known for | Founder of DUSA Pharmaceuticals; commercialization of Levulan photodynamic therapy |
| Title | Chairman, president and chief executive officer of DUSA Pharmaceuticals |
| Spouse | Charlene Linzon |
| Children | 5 |
| Parent(s) | Morton Shulman and Gloria Shulman |
| Relatives | Dianne Saxe (sister) |
David Geoffrey Shulman (July 8, 1954 – July 2, 2012) was a Canadian dermatologist and pharmaceutical executive. He founded DUSA Pharmaceuticals and served as its chairman, president and chief executive officer, leading the commercialization of Levulan photodynamic therapy, a treatment using aminolevulinic acid and blue light. In 1999, Levulan became the first topical photodynamic therapy approved in the United States for the treatment of actinic keratosis.